FDA Import Refusal 799-8952873-4/10003/1 — SANDOZ CANADA INCORPORATED
The FDA refused shipment 799-8952873-4/10003/1 from SANDOZ CANADA INCORPORATED (Canada) on December 22, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 22, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75